Editorial: How does the risk of hepatocellular carcinoma change over time in patients with a hepatitis C cure? Authors' reply

Aliment Pharmacol Ther. 2024 Feb;59(3):419-420. doi: 10.1111/apt.17841.

Philip Vutien^{1

2}, Nicole J Kim^{1

2}, Andrew M Moon^{3

4}, Kay M Johnson^{5

6}, Kristin Berry⁷, Pamela K Green⁷, George N Ioannou^{1

2

7}

¹ Division of Gastroenterology and Hepatology, University of Washington, Seattle, Washington, USA.
² Division of Gastroenterology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
³ Division of Gastroenterology and Hepatology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
⁴ Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
⁵ Hospital and Specialty Medicine, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
⁶ Division of General Internal Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
⁷ Health Service Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.

No abstract available

Publication types